Electromed (ELMD) Net Equity Issued and Repurchased (2010 - 2019)
Electromed (ELMD) posted quarterly Net Equity Issued and Repurchased of $13040.0 for Q3 2019, down 61.15% year-over-year from $33568.0 in Q3 2018, and down 61.15% quarter-over-quarter from $33568.0 in Q3 2018.
Electromed (ELMD) Net Equity Issued and Repurchased (2010 - 2019) Analysis & Trends
Electromed (ELMD) has reported Net Equity Issued and Repurchased for 3 consecutive years, with $13040.0 the latest figure, recorded in Q3 2019.
- In Q3 2019, Net Equity Issued and Repurchased fell 61.15% year-over-year to $13040.0; the TTM figure through Sep 2019 stood at $46608.0 (up 71.59% YoY), while the FY2012 annual figure was $5.9 million, down 6.56% from the prior year.
- Net Equity Issued and Repurchased slipped to $13040.0 in Q3 2019 per ELMD's latest filing, from $33568.0 in the prior quarter.
- Across five years, Net Equity Issued and Repurchased topped out at $33568.0 in Q3 2018 and bottomed at $13040.0 in Q3 2019.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Equity Issued and Repurchased (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.44 Bn | 193.84 Bn | 7.27 Bn | - |
| 2 | Stryker | 127.32 Bn | 123.85 Bn | 4.50 Bn | - |
| 3 | Medtronic | 118.87 Bn | 109.65 Bn | 6.41 Bn | 97.00 Mn |
| 4 | Boston Scientific | 73.47 Bn | 72.93 Bn | 3.85 Bn | - |
| 5 | Edwards Lifesciences | 51.90 Bn | 47.65 Bn | 1.35 Bn | - |
| 6 | Dexcom | 34.30 Bn | 32.36 Bn | 830.00 Mn | - |
| 7 | GE HealthCare Technologies | 33.74 Bn | 31.63 Bn | 2.18 Bn | - |
| 8 | Koninklijke Philips | 26.35 Bn | 23.03 Bn | 4.55 Bn | - |
| 9 | Steris | 23.05 Bn | 22.56 Bn | 684.20 Mn | - |
| 10 | Electromed | 329.52 Mn | 312.53 Mn | 14.64 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2019 | 13,040.00 |
| Sep 30, 2019 | 13,040.00 |
| Sep 30, 2018 | 33,568.00 |
| Sep 30, 2018 | 33,568.00 |
| Dec 31, 2010 | -6,405.00 |
| Dec 31, 2010 | -6,405.00 |
| Sep 30, 2010 | 6.37 Mn |
| Sep 30, 2010 | 6.37 Mn |